Does Pfizer have completed or ongoing biomarker research which can be leveraged in addressing this topic? How do I incorporate that into my research plan or gain access to the data?
Pfizer partners with many companies, research groups, public and private institutions, etc. and has access to the results of such collaborations. As such it often has the right to use with other partners unpublished and/or proprietary biomarker data, knowledge, assays, technologies or samples. Where this may be leveraged in finding a solution to the problems addressed by the Proposal, there may be opportunities to gain time, increase value or reduce cost in achieving the objectives of the Proposal. Pfizer therefore expects bidders to be dynamic, responsive and open minded in response to Pfizer’s wider portfolio approach to solving the problems addressed under the Proposal in terms of how any relationship between the Pfizer and bidder may evolve.
Related Questions
- Does Pfizer have completed or ongoing biomarker research which can be leveraged in addressing this topic? How do I incorporate that into my research plan or gain access to the data?
- At Case Conference, Research Conference, and similar meetings faculty and fellows discuss their ongoing research. Do we need to have biosketches and objectives for each?
- What areas of research is TTIC addressing?
